Lactacystin ≥99%

Supplier: Enzo Life Sciences

BML-PI104-0200 BML-PI104-1000
89161-574EA 289.14 CAD
89161-574 89161-576
Lactacystin ≥99%
Lactacystin

Key inhibitor for use in proteasome research.


A potent and selective irreversible proteasome inhibitor. Specifically inhibits 20S proteasome (MCP; multicatalytic complex). Blocks proteasome activity by targeting the catalytic beta-subunit. Has no effect on serine or cysteine proteases. Induces apoptosis inhuman monoblast U937 cells. Inhibits NF-kappaB activation by inhibiting IkappaB degradation (IC50=10 µM). Inhibits the ubiquitin proteasome pathway in cell culture. Inhibits cathepsin A. Upregulates HSP70 and HSP22, suggesting an initial neuroprotective pathway. Induces neurite outgrowth in Neuro 2A mouse neuroblastoma cells.


Synthetic

Formula: C₁₅H₂₄N₂O₇S
MW: 376.4 g/mol
CAS Number: 133343-34-7

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR